Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens Köllermann

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
International Journal of Urology : Official Journal of the Japanese Urological Association|November 23, 2011
Combined histoarchitectural and cytological biopsy grading improves grading accuracy in low-grade prostate cancerBurkhard Helpap, Jens Köllermann
Case Reports in Pathology|April 16, 2021
Leydig Cell Tumor in a Patient with 46,XX Disorder of Sex Development (DSD), Ovotesticular: A Case Report and a Review of the LiteratureSteffen Gretser, Maria-Noemi Welte, Frederik Roos, et al.
Der Pathologe|June 25, 2021
[Metastatic castration-resistant prostate cancer]Vanessa Henriques, Mike Wenzel, Melanie-Christin Demes, et al.
Pathology Oncology Research : POR|April 24, 2010
Nuclear grading versus Gleason grading in small samples containing prostate cancer: a tissue microarray studyDaniel Wittschieber, Jens Köllermann, Thorsten Schlomm, et al.
Oncotarget|March 7, 2022
Sequencing of <i>BRCA1/2</i>-alterations using NGS-based technology: annotation as a challengeSilvana Ebner, Ria Winkelmann, Saskia Martin, et al.
Oncotarget|August 30, 2023
Addendum: Sequencing of <i>BRCA1/2</i>-alterations using NGS-based technology: annotation as a challengeSilvana Ebner, Ria Winkelmann, Saskia Martin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2008
Prognostic significance of disseminated tumor cells in the bone marrow of prostate cancer patients treated with neoadjuvant hormone treatmentJens Köllermann, Steffen Weikert, Martin Schostak, et al.
European Urology|October 24, 2003
Methylation-specific PCR for DNA-based detection of occult tumor cells in lymph nodes of prostate cancer patientsJens Köllermann, Markus Müller, Carsten Goessl, et al.
Virchows Archiv : an International Journal of Pathology|June 3, 2026
An artificial intelligence solution for evaluation of prostate needle core biopsy specimens: impact in a non-specialist settingGerald Niedobitek, Gernot Schmitz, Manuel Fella, et al.
Urology|August 30, 2003
Follow-up of nondetectable prostate carcinoma (pT0) after prolonged PSA-monitored neoadjuvant hormonal therapy followed by radical prostatectomyJens Köllermann, Jörg Caprano, Anke Budde, et al.
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
International Journal of Urology : Official Journal of the Japanese Urological Association|November 23, 2011
Combined histoarchitectural and cytological biopsy grading improves grading accuracy in low-grade prostate cancerBurkhard Helpap, Jens Köllermann
Case Reports in Pathology|April 16, 2021
Leydig Cell Tumor in a Patient with 46,XX Disorder of Sex Development (DSD), Ovotesticular: A Case Report and a Review of the LiteratureSteffen Gretser, Maria-Noemi Welte, Frederik Roos, et al.
Der Pathologe|June 25, 2021
[Metastatic castration-resistant prostate cancer]Vanessa Henriques, Mike Wenzel, Melanie-Christin Demes, et al.
Pathology Oncology Research : POR|April 24, 2010
Nuclear grading versus Gleason grading in small samples containing prostate cancer: a tissue microarray studyDaniel Wittschieber, Jens Köllermann, Thorsten Schlomm, et al.
Oncotarget|March 7, 2022
Sequencing of <i>BRCA1/2</i>-alterations using NGS-based technology: annotation as a challengeSilvana Ebner, Ria Winkelmann, Saskia Martin, et al.
Oncotarget|August 30, 2023
Addendum: Sequencing of <i>BRCA1/2</i>-alterations using NGS-based technology: annotation as a challengeSilvana Ebner, Ria Winkelmann, Saskia Martin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2008
Prognostic significance of disseminated tumor cells in the bone marrow of prostate cancer patients treated with neoadjuvant hormone treatmentJens Köllermann, Steffen Weikert, Martin Schostak, et al.
European Urology|October 24, 2003
Methylation-specific PCR for DNA-based detection of occult tumor cells in lymph nodes of prostate cancer patientsJens Köllermann, Markus Müller, Carsten Goessl, et al.
Virchows Archiv : an International Journal of Pathology|June 3, 2026
An artificial intelligence solution for evaluation of prostate needle core biopsy specimens: impact in a non-specialist settingGerald Niedobitek, Gernot Schmitz, Manuel Fella, et al.
Urology|August 30, 2003
Follow-up of nondetectable prostate carcinoma (pT0) after prolonged PSA-monitored neoadjuvant hormonal therapy followed by radical prostatectomyJens Köllermann, Jörg Caprano, Anke Budde, et al.
Pageof 9